了解性激素在跨性别群体癌症中的作用。
Understanding the role of sex hormones in cancer for the transgender community.
机构信息
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Brighton & Sussex University Hospitals NHS Trust, Brighton, UK; Welsh Gender Service, Cardiff and Vale University Health Board, Cardiff, UK.
出版信息
Trends Cancer. 2022 Apr;8(4):273-275. doi: 10.1016/j.trecan.2022.01.005. Epub 2022 Jan 31.
Abstract
Sex hormones are crucial for the body's development and function. Therefore, many transgender people seek hormone therapy as part of their transition. However, sex hormones modulate cancer risk. Studying sex hormones in cisgender and transgender populations will improve our knowledge of their biological role in cancer and reduce health disparities.
摘要
性激素对于身体的发育和功能至关重要。因此，许多跨性别者寻求激素疗法作为其转变过程的一部分。然而，性激素会调节癌症风险。研究顺性别和跨性别人群中的性激素将提高我们对其在癌症中的生物学作用的认识，并减少健康差距。
相似文献
1
Understanding the role of sex hormones in cancer for the transgender community.了解性激素在跨性别群体癌症中的作用。
Trends Cancer. 2022 Apr;8(4):273-275. doi: 10.1016/j.trecan.2022.01.005. Epub 2022 Jan 31.
2
Cancer Risk in Transgender People.跨性别者的癌症风险。
Endocrinol Metab Clin North Am. 2019 Jun;48(2):441-452. doi: 10.1016/j.ecl.2019.02.005. Epub 2019 Mar 23.
3
Risk Factors for Eating Disorder Psychopathology within the Treatment Seeking Transgender Population: The Role of Cross-Sex Hormone Treatment.寻求治疗的跨性别群体中饮食障碍心理病理学的风险因素：跨性别激素治疗的作用。
Eur Eat Disord Rev. 2018 Mar;26(2):120-128. doi: 10.1002/erv.2576. Epub 2018 Jan 10.
4
Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.跨性别激素对跨性别者生活质量、抑郁和焦虑的影响：一项定量系统评价。
JBI Database System Rev Implement Rep. 2019 Sep;17(9):1826-1854. doi: 10.11124/JBISRIR-2017-003869.
5
CARDIOVASCULAR HEALTH MAINTENANCE IN AGING INDIVIDUALS: THE IMPLICATIONS FOR TRANSGENDER MEN AND WOMEN ON HORMONE THERAPY.心血管健康维护在老年个体中的应用：激素治疗对跨性别男性和女性的影响。
Endocr Pract. 2021 Jan;27(1):63-70. doi: 10.1016/j.eprac.2020.11.001. Epub 2020 Dec 13.
6
Insights Into the Cardiomodulatory Effects of Sex Hormones: Implications in Transgender Care.深入了解性激素的心脏调节作用：对跨性别护理的影响。
Hypertension. 2023 Sep;80(9):1810-1820. doi: 10.1161/HYPERTENSIONAHA.123.19501. Epub 2023 Jul 18.
7
What has sex got to do with it? The role of hormones in the transgender brain.性与这有什么关系？激素在跨性别者大脑中的作用。
Neuropsychopharmacology. 2019 Jan;44(1):22-37. doi: 10.1038/s41386-018-0140-7. Epub 2018 Jul 5.
8
Chronotype changes after sex hormone use: A prospective cohort study in transgender users of gender-affirming hormones.使用性激素后时型改变：性别肯定激素使用的跨性别者前瞻性队列研究。
Chronobiol Int. 2024 May;41(5):658-668. doi: 10.1080/07420528.2024.2339989. Epub 2024 Apr 14.
9
MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.内分泌疾病管理：跨性别者的最佳女性激素治疗。
Eur J Endocrinol. 2021 Jun 28;185(2):R49-R63. doi: 10.1530/EJE-21-0059.
10
Cross-Sex Hormones and Acute Cardiovascular Events in Transgender Persons.跨性别者的跨性别激素与急性心血管事件
Ann Intern Med. 2019 Jan 15;170(2):142-143. doi: 10.7326/L18-0563.
引用本文的文献
1
The Burden of Cancer and Precancerous Conditions Among Transgender Individuals in a Large Health Care Network: Retrospective Cohort Study.大型医疗保健网络中跨性别者的癌症及癌前病变负担：回顾性队列研究
JMIR Cancer. 2025 Sep 8;11:e73843. doi: 10.2196/73843.
2
Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review.激素致癌作用对接受性别确认激素治疗的跨性别者和性别多样化人群的影响：最新综述
BMJ Oncol. 2024 May 31;3(1):e000330. doi: 10.1136/bmjonc-2024-000330. eCollection 2024.
3
Tumour Immunotherapy and Applications of Immunological Products: A Review of Literature.肿瘤免疫治疗与免疫制品应用：文献综述。
J Immunol Res. 2024 Oct 24;2024:8481761. doi: 10.1155/2024/8481761. eCollection 2024.
4
Epigenetic developmental mechanisms underlying sex differences in cancer.癌症中性别差异的表观遗传发育机制。
J Clin Invest. 2024 Jul 1;134(13):e180071. doi: 10.1172/JCI180071.
5
The Burden of Cancer and Pre-cancerous Conditions Among Transgender Individuals in a Large Healthcare Network.大型医疗网络中跨性别者的癌症及癌前病变负担
medRxiv. 2024 Mar 26:2024.03.24.24304777. doi: 10.1101/2024.03.24.24304777.
6
Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations.意大利医学肿瘤学协会关于跨性别者和性别多样化人群健康差异的立场文件：阿西西建议
EClinicalMedicine. 2023 Oct 17;65:102277. doi: 10.1016/j.eclinm.2023.102277. eCollection 2023 Nov.
7
Cancer risk among transgender adults: A growing population with unmet needs.跨性别成年人中的癌症风险：一个需求未得到满足的不断增长的群体。
Acta Obstet Gynecol Scand. 2023 Nov;102(11):1428-1430. doi: 10.1111/aogs.14686.
8
Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data.跨性别和性别多样化个体癌症风险因素的流行情况：利用英国初级保健数据进行的横断面分析。
Br J Gen Pract. 2023 Jun 29;73(732):e486-e492. doi: 10.3399/BJGP.2023.0023. Print 2023 Jul.
9
Reinforcing or Disrupting Gender Affirmation: The Impact of Cancer on Transgender Embodiment and Identity.强化或破坏性别认同：癌症对跨性别者身体和身份认同的影响。
Arch Sex Behav. 2023 Apr;52(3):901-920. doi: 10.1007/s10508-023-02530-9. Epub 2023 Jan 23.
本文引用的文献
1
Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study.使用性别肯定激素治疗的跨性别女性的睾丸癌发病率：一项全国性队列研究。
BJU Int. 2022 Apr;129(4):491-497. doi: 10.1111/bju.15575. Epub 2021 Aug 30.
2
Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank.内源性激素与绝经前和绝经后妇女浸润性乳腺癌风险：来自英国生物银行的研究结果。
Br J Cancer. 2021 Jul;125(1):126-134. doi: 10.1038/s41416-021-01392-z. Epub 2021 Apr 16.
3
Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States.美国跨性别患者的癌症分期、治疗和生存情况。
J Natl Cancer Inst. 2021 Sep 4;113(9):1221-1227. doi: 10.1093/jnci/djab028.
4
Inclusion of transgender and gender diverse health data in cancer biorepositories.在癌症生物样本库中纳入跨性别者和性别多样化人群的健康数据。
Contemp Clin Trials Commun. 2020 Jun 16;19:100597. doi: 10.1016/j.conctc.2020.100597. eCollection 2020 Sep.
5
Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment.雄激素剥夺治疗下的前列腺癌发病率：接受激素治疗的跨性别女性的全国队列研究。
J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3293-9. doi: 10.1210/clinem/dgaa412.
6
Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review.激素和激素疗法对跨性别患者乳腺组织的影响：简要综述。
Endocrine. 2020 Apr;68(1):6-15. doi: 10.1007/s12020-020-02197-5. Epub 2020 Feb 17.
7
Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.接受激素治疗的跨性别者的乳腺癌风险：荷兰全国队列研究。
BMJ. 2019 May 14;365:l1652. doi: 10.1136/bmj.l1652.
8
Cancer Risk in Transgender People.跨性别者的癌症风险。
Endocrinol Metab Clin North Am. 2019 Jun;48(2):441-452. doi: 10.1016/j.ecl.2019.02.005. Epub 2019 Mar 23.
9
Endocrinology of Transgender Medicine.《 transgender 医学内分泌学》
Endocr Rev. 2019 Feb 1;40(1):97-117. doi: 10.1210/er.2018-00011.
10
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.游离睾酮水平低与前列腺癌风险：20 项前瞻性研究的协作分析。
Eur Urol. 2018 Nov;74(5):585-594. doi: 10.1016/j.eururo.2018.07.024. Epub 2018 Aug 1.
Zotero 插件